Eterna Health, in partnership with Dr. Adeel Khan, a leading expert in regenerative medicine, has launched a revolutionary therapy that utilizes Small Pluripotent Stem Cells (SPSCs). This advancement represents a significant evolution beyond traditional Platelet-Rich Plasma (PRP) therapy, tapping into the body”s inherent regenerative capabilities for improved healing and tissue restoration.
While PRP therapy has been widely recognized for promoting healing through concentrated growth factors, SPSCs provide a more comprehensive and effective approach to regeneration. These rare, stem-like cells, found in small amounts in adult blood, not only signal for tissue repair but also directly contribute to the regeneration of damaged areas, leading to superior recovery outcomes.
Isolated from a standard blood sample, SPSCs are less than five micrometers in size and express crucial pluripotency markers such as OCT4, NANOG, SOX2, and SSEA-4, indicating their potential to differentiate into various tissue types. Using a proprietary cold-enrichment method developed in Eterna Health”s laboratories, between 200 and 500 million viable SPSCs can be safely extracted from just 60 milliliters of blood. Their small size enables them to circulate efficiently throughout the body, avoiding the common issue of larger cells becoming trapped in the lungs.
Preliminary clinical findings suggest that SPSCs are safe and show promising potential, with no observed tumor risk and positive early results. This breakthrough signifies the advent of a next-generation tool in regenerative medicine that could redefine cellular therapy standards. “PRP gives the body the signal to heal. SPSCs supply the mechanism,” explained Dr. Khan, who serves as CEO and Founder of Eterna Health. “By leveraging the body”s own regenerative capacity, we can move beyond merely signaling to actively facilitating cellular repair and renewal in a safe, effective, and natural manner.”
The novel therapy is derived from the patient”s own blood and involves minimal manipulation, adhering to safety regulations established by agencies such as the FDA and EMA for regenerative medicine. This ensures biological compatibility and eliminates risks associated with cultured or genetically modified stem cells.
Dr. Khan emphasized, “Safety, science, and transparency are the foundation of our work. Our process is grounded in solid biology and clinical standards, maintaining a deep respect for patient trust. SPSCs represent a vital step in the evolution of responsible, evidence-based regenerative care.”
Recognized globally for his expertise in regenerative medicine, Dr. Khan has collaborated with elite athletes, longevity researchers, and respected health organizations to promote safe and evidence-backed applications of stem cell science. He is steering Eterna Health to integrate the developing landscape of regenerative medicine with clinical and patient-focused research, ensuring that new technologies are validated in a clinical context.
Through this therapy, Eterna Health solidifies its position as a frontrunner in regenerative and functional medicine. By merging academic rigor with patient-centered innovation, the clinic continues to offer accessible, ethical, and effective treatments that utilize the body”s natural ability to heal itself.
